We proudly announced the publication of breakthrough research demonstrating the effectiveness of binocular vision therapy using the Bynocs #SquintEase program for intermittent exotropia management. This work represents a major step forward in the field of binocular vision science.
Thanks to Dr. Pradeep Sharma and our dedicated multidisciplinary team, this milestone advanced the standard of patient care, showcased evidence-based excellence, and redefined the possibilities of binocular vision therapy worldwide.
On Friday, September 12, 2025, at 8:00 PM CEST, Mr. Oliullah Abdal, Co-founder and Director of Bynocs, took a session on Emerging Technology during the WSPOS Subspecialty Day at ESCRS 2025, where groundbreaking advancements in pediatric eye care took center stage.
We are delighted to share that Bynocs was the only global company invited to take part in this prestigious Innovation Challenge, which spotlighted digital therapeutics for amblyopia and binocular vision disorders. Our cutting-edge solutions received tremendous appreciation for redefining how clinicians approach vision therapy and treatment for children worldwide. The session was well appreciated by ophthalmologists, eyecare specialists and eye surgeons from across the world.
The event marked a significant milestone for Bynocs, as pediatric ophthalmologists from around the world engaged with us, learned about the future of vision therapy, and explored how our technology is driving transformation in amblyopia and binocular vision care. The event reinforced Bynocs’ position as the world leader in binocular vision therapy, driving the future of digital pediatric eye health.
Bynocs proudly participated in POSN 7.0 – Paediatric Ophthalmology Scientific Fest at IIC, New Delhi, which saw enthusiastic participation from pediatric ophthalmologists and practitioners. Our AmblyGo and SquintEase digital therapy platforms were highly appreciated for their innovation, scientific validation, and clinical effectiveness.
The event fostered rich collaboration and reaffirmed Bynocs’ global leadership in binocular vision therapy, setting new benchmarks in pediatric eye care through technology-driven, evidence-based solutions.
